Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Takeda Consumer Healthcare Co. Ltd.

www.takeda.com

Latest From Takeda Consumer Healthcare Co. Ltd.

APAC Life Sciences Valuation Trends: Chinese Firms Eclipse Japan, India Peers

Chinese healthcare and life sciences firms now overshadow their peers in Japan and India in terms of key valuation metrics amid COVID-19 and China has also witnessed significant M&A activity at high revenue multiples.

Commercial Coronavirus COVID-19

Takeda Expects Stronger Net Profit On Lower Tax

Entyvio strong again for Japanese firm as it raises net profit forecast on lower tax costs. Meanwhile, 'Wave 1' pipeline projects are progressing, with simultaneous development in major markets a key goal. 

Commercial Business Strategies

Another Divestment By Takeda, To China’s Hasten For $322m

Japanese major sheds further non-core assets as it continues to focus on innovation and pay down debt following the Shire acquisition.

China Commercial

Takeda Confirms $2.3bn Deal With Blackstone For Japan Consumer Business

In a widely anticipated move, Takeda has confirmed the sale of its consumer healthcare business in Japan, to the US private equity group Blackstone.

Japan Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register